General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

People

The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 11 members and Dr. Reinhardt acts as chairman effective August 1, 2013.

Download the Novartis organizational structure (83 KB)

  • Joerg Reinhardt, Ph.D.
    Chairman

    Read biography:

  • Ulrich Lehner, Ph.D.
    Vice Chairman

    Read biography:

  • Enrico Vanni, Ph.D.
    Vice Chairman

    Read biography:

  • Dimitri Azar, M.D., MBA

    Read biography:

  • Verena A. Briner, M.D.

    Read biography:

  • Srikant Datar, Ph.D.

    Read biography:

  • Ann Fudge

    Read biography:

  • Pierre Landolt, Ph.D.

    Read biography:

  • Andreas von Planta, Ph.D.

    Read biography:

  • Charles L. Sawyers, M.D.

    Read biography:

  • William T. Winters

    Read biography:

Corporate Secretary

  • Charlotte Pamer-Wieser, Ph.D.

    Read biography: